NCT02534649
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials
Campos del registro
- Estado general
- RECRUITING
- Condiciones
- Solid Tumor, Hematological Malignancy
- Tipo de estudio
- INTERVENTIONAL
- Fase
- NA
- Objetivo principal
- DIAGNOSTIC
- Tipo de intervención
- PROCEDURE
- Intervenciones
- Newly obtained biopsy and Blood samples collection
- Patrocinador principal
- Institut Bergonié (OTHER)
En caché: 2026-10-09 01:26:55
Resumen breve
This is a biology driven, monocentric study designed to identify actionable molecular alterations in cancer patients with advanced disease.
In this trial, high throughput analysis will be carried out using next generation sequencing, and immunological profiling.
Patients included in the BIP study and for whom a targetable genomic alteration had been identified might be subsequently included in an early phase trials running at Institut Bergonie or another French hospital.
In this trial, high throughput analysis will be carried out using next generation sequencing, and immunological profiling.
Patients included in the BIP study and for whom a targetable genomic alteration had been identified might be subsequently included in an early phase trials running at Institut Bergonie or another French hospital.
Contacto
¿Necesita un informe o redacción médica basada en este ensayo?
Iniciar sesión con Kakao para continuar